Clinical Trial: An observational study on the impact of immune checkpoint inhibitors combined with CAPOX as firstline therapy on quality of life in patients with HER2negative advanced gastric cancer (China)

Posted On: 2026-09-07

China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An observational study on the impact of immune checkpoint inhibitors combined with CAPOX as firstline therapy on quality of life in patients with HER2negative advanced gastric cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131617

Registration Time: 2026/09/04

Type: Observational study

Primary Sponsor: The First Affiliated Hospital of Anhui Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341841

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: An observational study on the impact of immune checkpoint inhibitors combined with CAPOX as firstline therapy on quality of life in patients with HER2negative advanced gastric cancer (China)